Monday, April 27, 2009
Heard of Priligy (Dapoxetine)?
I saw a sign today that caught my attention (I won't tell you where I saw it, but you can probably take a guess). It was for a new drug called Priligy (Dapoxetine). This agent has been approved in several countries in Europe ,but not in the USA. Approved for what? For premature ejaculation. The drug is an SSRI (selective serotonin reuptake inhibitor), similar to those used to treat depression and anxiety. However, it is a short-acting formulation and is meant to be taken "as needed." It is currently approved in Sweden and Finland and is marketed by Janssen-Cilag, a part of the Johnson & Johnson family of companies.
Sexual health is one of those topics that many healthcare professionals don't really like to talk about. When new drugs like Viagra, Cialis, and Levitra emerged on the scene, this allowed clinicians to be a bit more comfortable having open conversations with their patients about sexual topics. So which topic is more uncomfortable to discuss: erectile dysfunction or premature ejaculation?
Labels: dapoxetine, FDA, FDA new drugs, Johnson and Johnson, Priligy, psychiatry, SSRI
Subscribe to: Post Comments (Atom)
Post a Comment